BioCardia, Inc. Share-based Payment Arrangement, Amount Capitalized
BioCardia, Inc. (BCDA) reported Share-based Payment Arrangement, Amount Capitalized of $0 for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Expensed and Capitalized, Amount
us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2022-03-29
- BioCardia, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2020-09-30 was $0.00.
- BioCardia, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2020-06-30 was $0.00.
- BioCardia, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2020-03-31 was $0.00.
- BioCardia, Inc. share-based payment arrangement, amount capitalized for the quarter ending 2019-09-30 was $0.00.
| Period end | Share-based Payment Arrangement, Amount Capitalized | Share-based Payment Arrangement, Amount Capitalized 3 month | Share-based Payment Arrangement, Amount Capitalized 6 month | Share-based Payment Arrangement, Amount Capitalized 9 month |
|---|---|---|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-15 | |||
| 2020-01-29 | $157.00K 10-K · filed 2022-03-29 | |||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-19 | $0.00 derived: sum of 2 quarters · filed 2019-11-19 | $0.00 10-Q · filed 2019-11-19 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | |||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-19 | $0.00 derived: sum of 2 quarters · filed 2019-11-19 | $0.00 10-Q · filed 2019-11-19 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |